All posts by: Michael Zand

About Michael Zand

Danish Biotech Raises Series A Round to Advance Biocatalyst Technology – Labiotech.eu (blog)

Continue reading

2018-05-23 NEWS

Danish Biotech Raises Series A Round to Advance Biocatalyst Technology
Labiotech.eu (blog)
Other key players in the synthetic biology field include Antheia and e-NIOS. Antheia uses synthetic biology to develop plant-based medicines. e-NIOS’s cloud platform technology can analyze genetic data from a variety of sources and apply the

Continue reading

2018-05-23 NEWS

FiercePharma

Novartis’ brand-new gene therapy player AveXis will build $55M plant, hire 200
FiercePharma
“Our primary focus is to bring gene therapies to patients suffering from devastating rare neurological diseases—such as SMA, genetic amyotrophic lateral sclerosis and Rett syndrome—and continued investment in establishing our manufacturing
Gene therapy company to create 200 jobs in North Carolina :: WRAL …WRAL.com
Gene therapy company to create 200 jobs in North CarolinaSacramento Bee

all 6 news articles »

Continue reading

2018-05-23 NEWS

BioPharma-Reporter.com

Stem cell clinic to ‘vigorously defend’ US FDA lawsuit
BioPharma-Reporter.com
The lawsuit seeks to stop USRM and related parties from performing a surgical procedure using stem cells from autologous adipose tissue. Dr. Kristin Comella, chief science officer of US Stem Cell, told us in a statement: “My entire career has been
Where bioengineering and stem cell science meet, and thriveScope (blog)
Mapping the Genes Responsible for PluripotencyNews-Medical.net
[Doctors with Patents] SNUH professor pursues stem cell research for real-life therapiesKim Hyo-soo pushes forward …Korea Biomedical Review
Technical Progress –Expert Consulting –Exclusive Reportage
all 45 news articles »
Continue reading

2018-05-23 NEWS

WRAL.com

Gene therapy company to create 200 jobs in North Carolina
WRAL.com
DURHAM, N.C. — A gene therapy company says it will create 200 jobs in North Carolina. AveXis on Tuesday agreed to set up operations in Durham County, after getting a state incentive package worth up to $3 million. AveXis makes treatments for spinal …
Novartis’ brand-new gene therapy player AveXis will build $55M plant, hire 200FiercePharma

all 6 news articles »

Continue reading

2018-05-23 NEWS

WRAL.com

Gene therapy company to create 200 jobs in North Carolina
WRAL.com
DURHAM, N.C. — A gene therapy company says it will create 200 jobs in North Carolina. AveXis on Tuesday agreed to set up operations in Durham County, after getting a state incentive package worth up to $3 million. AveXis makes treatments for spinal …
Novartis’ brand-new gene therapy player AveXis will build $55M plant, hire 200FiercePharma

all 6 news articles »